| Name | Title | Contact Details |
|---|
We love what we do and we are committed to providing the best senior financial executive talent to our clients through a variety of offerings, including: interim, project, and search. Further, we’ve built a firm capable of serving companies of any size and from any industry. Our CFO Partners and executive-level resources are CPAs and MBAs with an average of twenty-five years of senior-level strategic and operational finance experience. We have gained this experience while serving on the front lines of multiple industries in companies large and small. Whether your company is in need of strong, visionary financial leadership, or in need of highly competent tactical support on a departmental basis, you can turn to CSuite Financial Partners to satisfy all your financial-talent needs.
V.S.B. Associates is a Bethesda, MD-based company in the Business Services sector.
QuickSet provides highly durable azimuth/ elevation control mounts and tripods for some of the most demanding payload conditions. Our platforms are used in military, transit, broadcasting, microwave and countless other applications. With more than
CDI Engineering Solutions is a multi-disciplinary organization offering engineering, architecture, and allied technical expertise to a variety of markets.
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.